Trial Profile
A study assessing utilization patterns of P2Y12 inhibitors in patients referred for invasive evaluation of coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 09 Oct 2016 New trial record